Clark William Perry is a notable inventor based in North Bergen, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of radiolabeled compounds. With a total of 4 patents to his name, Perry's work has implications in various scientific applications.

Latest Patents

Among his latest patents is a compound known as Radiolabeled benzazepine. This compound is described by a specific formula, wherein T is tritium. It is particularly useful in assays for detecting the presence of benzodiazepine receptor occupiers in warm-blooded animals. Additionally, he has worked on the efficient resolution of salts of N-formyl-6-chlorotryptophan and racemic organic carboxylic acids into their enantiomers using antipodes of α-methyl-p-nitrobenzylamine.

Career Highlights

Clark William Perry has had a distinguished career, primarily working with Hoffmann-La Roche Inc. His innovative approaches and research have contributed to advancements in the pharmaceutical industry. His expertise in radiolabeled compounds has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Perry has collaborated with esteemed colleagues, including Sidney Teitel and Arnold A Liebman. These collaborations have fostered a productive environment for innovation and research.

Conclusion

In summary, Clark William Perry is a prominent inventor whose work in radiolabeled compounds has made a significant impact in the field of chemistry. His contributions continue to influence scientific research and applications.